22377

543220

MAXHEALTH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MAX HEALTHCARE INS LTD Share Price Today

MAX HEALTHCARE INS LTD is currently trading at ₹1093, down by ₹2.05 from the previous close. The stock touched an intraday high of ₹1081.55 and a low of ₹1081.55 during the latest trading session. Over the past one year, MAX HEALTHCARE INS LTD has delivered a loss of 5.86%, while the stock has gained 2.43% in the last one month.

MAX HEALTHCARE INS LTD performance

Today’s low Today’s high
₹ 1081.55 ₹ 1081.55
₹ 1092.05
52 week low 52 week high
₹ 903.00 ₹ 1314.30
₹ 1092.05
Open Price ₹ 1081.55
Prev. Close ₹ 1095.05
Volume (Shares) 1119734.00
Total traded value ₹ 12228.05
Upper Circuit ₹ 1204.55
Lower Circuit ₹ 985.55
info

Investment Returns

Over 1 Month 2.43% Over 3 Months 14.86% Over 6 Months 1.76% Over 1 Year -5.86%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MAX HEALTHCARE INS LTD fundamentals


  • Market cap (Cr) 1,06,283.10
  • P/E Ratio (TTM) 148.92
  • Beta 0.74
  • Book Value / share 91.86
  • Return on equity 8.78%
  • EPS (TTM) 7.49
  • Dividend yield 0.18%
  • Net profit/quarter (Cr) 203.21
info icon alternate text
  • Market cap (Cr) 1,06,755.10
  • P/E Ratio (TTM) 148.92
  • Beta 0.67
  • Book Value / share 91.86
  • Return on equity 8.78%
  • EPS (TTM) 7.49
  • Dividend yield 0.18%
  • Net profit/quarter (Cr) 203.21
info icon alternate text

MAX HEALTHCARE INS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 732.90
Operating Expense 563.86
Net Profit 203.21
Net Profit Margin (%) 27.72
Earnings Per Share (EPS) 2.09
EBITDA 306.21
Effective Tax Rate (%) 21.95
Particulars DEC 2025 (Values in Cr)
Revenue 710.91
Operating Expense 553.40
Net Profit 186.95
Net Profit Margin (%) 26.29
Earnings Per Share (EPS) 1.92
EBITDA 272.02
Effective Tax Rate (%) 16.98
Particulars SEP 2025 (Values in Cr)
Revenue 736.62
Operating Expense 568.39
Net Profit 160.42
Net Profit Margin (%) 21.77
Earnings Per Share (EPS) 1.65
EBITDA 261.09
Effective Tax Rate (%) 25.61
Particulars JUN 2025 (Values in Cr)
Revenue 694.02
Operating Expense 550.99
Net Profit 166.03
Net Profit Margin (%) 23.92
Earnings Per Share (EPS) 1.71
EBITDA 267.56
Effective Tax Rate (%) 25.50
Particulars MAR 2025 (Values in Cr)
Revenue 658.70
Operating Expense 529.62
Net Profit 177.39
Net Profit Margin (%) 26.93
Earnings Per Share (EPS) 1.82
EBITDA 272.76
Effective Tax Rate (%) 21.93
Particulars MAR 2026 (Values in Cr)
Revenue 2874.45
Operating Expense 2236.64
Net Profit 716.61
Net Profit Margin (%) 24.93
Earnings Per Share (EPS) 7.37
EBITDA 1106.89
Effective Tax Rate (%) 22.45
Particulars MAR 2025 (Values in Cr)
Revenue 2663.60
Operating Expense 2009.79
Net Profit 701.07
Net Profit Margin (%) 26.32
Earnings Per Share (EPS) 7.21
EBITDA 1126.30
Effective Tax Rate (%) 25.94
Particulars MAR 2024 (Values in Cr)
Revenue 2341.36
Operating Expense 1742.46
Net Profit 687.26
Net Profit Margin (%) 29.35
Earnings Per Share (EPS) 7.07
EBITDA 1033.26
Effective Tax Rate (%) 20.54
Particulars MAR 2023 (Values in Cr)
Revenue 1904.66
Operating Expense 1485.69
Net Profit 694.31
Net Profit Margin (%) 36.45
Earnings Per Share (EPS) 7.16
EBITDA 728.26
Effective Tax Rate (%) -23.29
Particulars MAR 2022 (Values in Cr)
Revenue 1775.36
Operating Expense 1502.99
Net Profit 331.52
Net Profit Margin (%) 18.67
Earnings Per Share (EPS) 3.43
EBITDA 571.38
Effective Tax Rate (%) 17.22
Particulars MAR 2025 (Values in Cr)
Book Value / Share 96.50
ROE % 12.10
ROCE % 13.46
Total Debt to Total Equity 0.24
EBITDA Margin 27.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 86.51
ROE % 13.37
ROCE % 14.96
Total Debt to Total Equity 0.13
EBITDA Margin 30.90
Particulars MAR 2023 (Values in Cr)
Book Value / Share 76.31
ROE % 16.12
ROCE % 13.85
Total Debt to Total Equity 0.12
EBITDA Margin 28.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.79
ROE % 10.15
ROCE % 11.09
Total Debt to Total Equity 0.17
EBITDA Margin 25.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.37
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin 20.69
Particulars MAR 2025 (Values in Cr)
Book Value / Share 85.27
ROE % 8.78
ROCE % 11.65
Total Debt to Total Equity 0.07
EBITDA Margin 42.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 79.03
ROE % 9.34
ROCE % 11.64
Total Debt to Total Equity 0.07
EBITDA Margin 42.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 72.53
ROE % 10.40
ROCE % 8.49
Total Debt to Total Equity 0.08
EBITDA Margin 36.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.09
ROE % 5.41
ROCE % 6.89
Total Debt to Total Equity 0.08
EBITDA Margin 30.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 61.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 24.75
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 681.89
Total Assets 15214.48
Total Liabilities 15214.48
Total Equity 9380.87
Share Outstanding 97
Price to Book Ratio 12.86
Return on Assets (%) 7.07
Return on Capital (%) 9.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1099.27
Total Assets 11999.94
Total Liabilities 11999.94
Total Equity 8408.14
Share Outstanding 97
Price to Book Ratio 10.38
Return on Assets (%) 8.81
Return on Capital (%) 11.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1468.07
Total Assets 10101.85
Total Liabilities 10101.85
Total Equity 7409.59
Share Outstanding 97
Price to Book Ratio 6.08
Return on Assets (%) 10.92
Return on Capital (%) 13.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 499.31
Total Assets 9189.13
Total Liabilities 9189.13
Total Equity 6282.47
Share Outstanding 96
Price to Book Ratio 5.33
Return on Assets (%) 6.58
Return on Capital (%) 8.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 652.92
Total Assets 8544.44
Total Liabilities 8544.44
Total Equity 5638.68
Share Outstanding 96
Price to Book Ratio 3.35
Return on Assets (%) -1.60
Return on Capital (%) -2.1
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 416.50
Total Assets 9967.22
Total Liabilities 9967.22
Total Equity 8289.36
Share Outstanding 97
Price to Book Ratio 12.86
Return on Assets (%) 7.03
Return on Capital (%) 7.97
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 720.04
Total Assets 9068.87
Total Liabilities 9068.87
Total Equity 7680.76
Share Outstanding 97
Price to Book Ratio 10.38
Return on Assets (%) 7.57
Return on Capital (%) 8.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1231.46
Total Assets 8420.33
Total Liabilities 8420.33
Total Equity 7042.11
Share Outstanding 97
Price to Book Ratio 6.08
Return on Assets (%) 8.24
Return on Capital (%) 9.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 386.51
Total Assets 7811.76
Total Liabilities 7811.76
Total Equity 6311.38
Share Outstanding 96
Price to Book Ratio 5.33
Return on Assets (%) 4.24
Return on Capital (%) 4.93
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 610.99
Total Assets 7142.95
Total Liabilities 7142.95
Total Equity 5939.43
Share Outstanding 96
Price to Book Ratio 3.35
Return on Assets (%) -2.30
Return on Capital (%) -2.62
Particulars MAR 2025 (Values in Cr)
Net Income 1406.37
Cash from Operations 1780.25
Cash from Investing -1631.74
Cash from Financing -163.80
Net change in Cash -336.23
Free Cash Flow 2745.77
Particulars MAR 2024 (Values in Cr)
Net Income 1365.32
Cash from Operations 1390.95
Cash from Investing -1285.45
Cash from Financing -263.74
Net change in Cash -427.52
Free Cash Flow 2176.90
Particulars MAR 2023 (Values in Cr)
Net Income 1063.72
Cash from Operations 1445.25
Cash from Investing -102.32
Cash from Financing -288.56
Net change in Cash 893.25
Free Cash Flow 1780.86
Particulars MAR 2022 (Values in Cr)
Net Income 738.90
Cash from Operations 849.58
Cash from Investing -763.80
Cash from Financing -294.17
Net change in Cash -317.45
Free Cash Flow 1402.92
Particulars MAR 2021 (Values in Cr)
Net Income -68.65
Cash from Operations 59.84
Cash from Investing -73.00
Cash from Financing 191.33
Net change in Cash 236.19
Free Cash Flow 178.26
Particulars MAR 2025 (Values in Cr)
Net Income 946.72
Cash from Operations 779.33
Cash from Investing -873.26
Cash from Financing -28.81
Net change in Cash -304.06
Free Cash Flow 1036.04
Particulars MAR 2024 (Values in Cr)
Net Income 864.96
Cash from Operations 761.78
Cash from Investing -805.64
Cash from Financing -245.91
Net change in Cash -438.46
Free Cash Flow 1223.13
Particulars MAR 2023 (Values in Cr)
Net Income 563.14
Cash from Operations 784.72
Cash from Investing -842.85
Cash from Financing -54.47
Net change in Cash -200.85
Free Cash Flow 905.22
Particulars MAR 2022 (Values in Cr)
Net Income 400.49
Cash from Operations 490.19
Cash from Investing -669.65
Cash from Financing -161.48
Net change in Cash -383.77
Free Cash Flow 861.18
Particulars MAR 2021 (Values in Cr)
Net Income -146.46
Cash from Operations 196.10
Cash from Investing -344.65
Cash from Financing 396.68
Net change in Cash 271.27
Free Cash Flow 227.51
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

MAX HEALTHCARE INS LTD shareholding pattern

Holding
4.57%
23.71%
45.38%
26.31%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

MAX HEALTHCARE INS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1092.05 -0.24 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1060.10
  • 26 Days 1019.30
  • 10 Days 1038.30
  • 50 Days 1014.70
  • 12 Days 1033.30
  • 100 Days 1024.60
  • 20 Days 1022.90
  • 200 Days 1049.80
1092.20 PIVOT
First Support 1081.65 First Resistance 1105.30 Second Support 1068.55 Second Resistance 1115.85 Third Support 1058.00 Third Resistance 1128.95
RSI 70.32 ADX 18.43 MACD 14.04 Williams % R -4.37 Commodity Channel Index (CCI) 206.69
Date 2026-06-19 Week 1171799.00 Same Day 1228526.00 Month 1978553.00
1 Year 0.75 3 Year 0.68
Over 1 Month
2.43% down
Over 1 Year
-5.86% down
Over 3 Months
14.86% down
Over 3 Years
22.08% down
Over 6 Months
1.76% down
Over 5 Years
34.75% down

MAX HEALTHCARE INS LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
04 Jul 2025 1.5 Final 04 Jul 2025 Equity shares
23 Aug 2024 1.5 Final 23 Aug 2024 Equity shares
08 Sep 2023 1.0 Final 08 Sep 2023 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
04 Jul 2025 1.5 Final 04 Jul 2025 Equity shares
23 Aug 2024 1.5 Final 23 Aug 2024 Equity shares
08 Sep 2023 1.0 Final 08 Sep 2023 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Max Healthcare Institute Ltd?

Answer Field

Max Healthcare Institute Ltd share price is for NSE ₹ 1,093.00 & for BSE ₹ 1,082.90 as on Jun 22 2026 03:30 PM.

What is the Market Cap of Max Healthcare Institute Ltd Share?

Answer Field

The market cap of Max Healthcare Institute Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jun 22 2026 03:30 PM.

What is the 52 Week High and Low of Max Healthcare Institute Ltd?

Answer Field

The 52 Week High and Low of Max Healthcare Institute Ltd for NSE is ₹ 1,314.30 and ₹ 903.00 and for BSE is ₹ 1,314.30 and ₹ 903.50.

What is 1 year return for Max Healthcare Institute Ltd?

Answer Field

The 1 year returns on the stock has been -5.86%.

What is the P/E Ratio of Max Healthcare Institute Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM the price-to-earnings (PE) ratio for Max Healthcare Institute Ltd share is 148.92.

What is the PB ratio of Max Healthcare Institute Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM, the price-to-book (PB) ratio for Max Healthcare Institute Ltd share is 91.86.

How to Buy Max Healthcare Institute Ltd Share?

Answer Field

You can trade in Max Healthcare Institute Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Max Healthcare Institute Ltd Share on Bajaj Broking App?

Answer Field

To buy Max Healthcare Institute Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Max Healthcare Institute Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|